Cytek Biosciences, Inc. (CTKB)

Last Closing Price: 5.92 (2026-11-18)

Long-Term Liabilities (Quarterly)

Long-Term Liabilities: The sum of all non-current liabilities.

Cytek Biosciences, Inc. (CTKB) had Long-Term Liabilities of $39.84M for the most recently reported fiscal quarter, ending 2026-09-30.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
$53.23M
$-6.10M
$22.02M
$31.21M
$61.65M
$-8.42M
$1.51M
$-6.91M
$-6.91M
$-6.10M
$-6.10M
$-6.10M
$-6.10M
$-8.42M
$-5.31M
130.36M
130.36M
$-0.05
$-0.05
Balance Sheet Financials
$378.94M
$20.61M
$67.21M
$446.14M
$84.95M
$0.10M
Long-Term Liabilities
$39.84M
$124.79M
$321.35M
$290.63M
$321.35M
130.77M
Cash Flow Statement Financials
$-5.82M
$-21.86M
$2.61M
$90.85M
$67.19M
$-23.66M
$15.05M
--
--
Fundamental Metrics & Ratios
4.46
--
--
0.00
0.00
58.63%
-15.82%
-15.82%
--
-12.98%
-11.45%
$-11.63M
--
--
--
0.12
0.42
0.90
100.08
-1.90%
-2.10%
-1.37%
-1.90%
$2.46
$-0.09
$-0.04